Pharma news
Americas
The US Court of Appeals for the Federal Circuit yesterday upheld a district court's decision that pharmaceutical company Exela infringed two patents covering Cadence Pharmaceuticals’s injectable Ofirmev, used for pain relief. 24 March 2015
Asia
The Delhi High Court has granted pharmaceutical company Merck an injunction that prevents Glenmark Pharmaceuticals from making and selling its diabetes drugs Zita and Zitamet. 24 March 2015
Pharma
Orphan medicinal products in Europe benefit from a range of incentives, but the greatest of these is the promise of receiving a ten-year period of true market exclusivity, says Trevor Cook of Wilmer Cutler Pickering Hale and Dorr. 20 March 2015
Americas
Bristol-Myers Squibb has sued generic drug maker Mylan for allegedly infringing a patent covering its HIV drug Reyataz. 20 March 2015
Pharma
Intellectual property is still seen as a “dirty term” in the EU, the assistant general counsel of pharmaceutical company GlaxoSmithKline has claimed. 19 March 2015
Americas
A US district court yesterday gave its opinion on how a group of disputed patent claims must be construed in a patent infringement case between Eisai and Novartis and several generic drug makers. 18 March 2015
Americas
Dublin-based pharmaceutical company Actavis has completed its acquisition of Allergan for $71 billion. 17 March 2015
Pharma
An Advocate General in the Court of Justice of the European Union, Niilo Jääskinen, has clarified how the regulation for supplementary protection certificates should be interpreted concerning medicinal products made with a combination of active ingredients. 13 March 2015
Americas
Japanese company Otsuka Pharmaceutical has sued drugs company Wockhardt for patent infringement at the US District Court for the District of New Jersey. 11 March 2015
Americas
The US Supreme Court yesterday refused to hear a case between Californian pharmaceutical company Gilead and India-based Natco that concerns ‘double patenting’. 10 March 2015